Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Matthew Robinson

Email
Center AffiliationsMolecular Therapeutics

Publications (29) (print view)

no pagination
Burns KE, Hensley H, Robinson MK, Thevenin D. Therapeutic Efficacy of a Family of pHLIP-MMAF Conjugates in Cancer Cells and Mouse Models. Molecular pharmaceutics. 2017 Jan 13;.
Burns KE, Hensley H, Robinson MK, Thevenin D. Therapeutic Efficacy of a Family of pHLIP-MMAF Conjugates in Cancer Cells and Mouse Models. Molecular pharmaceutics. 2017 Feb 06;14(2):415-22.   PMCID: PMC5293657
D'Souza JW, Hensley H, Doss M, Beigarten C, Torgov M, Olafsen T, Yu JQ, Robinson MK. Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers. J Nucl Med. 2017 Jan;58(1):175-80.   PMCID: PMC5209641
Haughey BH, Sinha P, Kallogjeri D, Goldberg RL, Lewis JS, Piccirillo JF, Jackson RS, Moore EJ, Brandwein-Gensler M, Magnuson SJ, Carroll WR, Jones TM, Wilkie MD, Lau A, Upile NS, Sheard J, Lancaster J, Tandon S, Robinson M, Husband D, Ganly I, Shah JP, Brizel DM, O'Sullivan B, Ridge JA, Lydiatt WM. Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncology. 2016 Nov;62:11-9.
Rajesh, Gao Z, Vishnubhotla R, Ducos P, Serrano MD, Ping J, Robinson MK, Johnson AT. Genetically Engineered Antibody Functionalized Platinum Nanoparticles Modified CVD-Graphene Nanohybrid Transistor for the Detection of Breast Cancer Biomarker, HER3. Advanced Materials Interfaces. 2016 Sep;3(17):1600124.
Burns KE, Robinson MK, Thévenin D. Inhibition of cancer cell proliferation and breast tumor targeting of phlip-monomethyl auristatin e conjugates. Molecular pharmaceutics. 2015 Jan;12(4):1250-8.   PMCID: 4476257
D'Souza JW, Robinson MK. Oligoclonal antibodies to target the ErbB family. Expert Opin Biol Ther. 2015 May 02;15(7):1015-21.   PMCID: 4480362
Lehmann A, Wixted JH, Shapovalov MV, Roder H, Dunbrack RL, Robinson MK. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach. MAbs. 2015 Nov 02;7(6):1058-71.   PMCID: 4966335
Ramirez UD, Nikonova AS, Liu H, Pecherskaya A, Lawrence SH, Serebriiskii IG, Zhou Y, Robinson MK, Einarson MB, Golemis EA, Jaffe EK. Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization. BMC cancer. 2015 Jan;15:436.   PMCID: 4451962
D'Souza JW, Reddy S, Goldsmith LE, Shchaveleva I, Marks JD, Litwin S, Robinson MK. Combining Anti-ERBB3 Antibodies Specific for Domain I and Domain III Enhances the Anti-Tumor Activity over the Individual Monoclonal Antibodies. PLoS One. 2014 Jan;9(11):e112376.   PMCID: Pmc4227695
Zhang J, Valianou M, Simmons H, Robinson MK, Lee HO, Mullins SR, Marasco WA, Adams GP, Weiner LM, Cheng JD. Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens. FASEB J. 2013 Feb;27(2):581-9.   PMCID: 3545529
Lerner MB, D'Souza J, Pazina T, Dailey J, Goldsmith BR, Robinson MK, Johnson AT. Hybrids of a Genetically Engineered Antibody and a Carbon Nanotube Transistor for Detection of Prostate Cancer Biomarkers. Acs Nano. 2012 Jun;6(6):5143-9.   PMCID: PMC3383883
Miller J, Doss M, McQuillen R, Shaller CC, Tolner B, Yu JQ, Chester K, Robinson MK. Impact of expression system on the function of the C6.5 diabody PET radiotracer. Tumor Biology. 2012 Jun;33(3):617-27.   PMCID: not NIH funded
Loo L, Capobianco JA, Wu W, Gao X, Shih WY, Shih WH, Pourrezaei K, Robinson MK, Adams GP. Highly sensitive detection of HER2 extracellular domain in the serum of breast cancer patients by piezoelectric microcantilevers. Anal Chem. 2011 May;83(9):3392-7.   PMCID: PMC3084889
Mehra R, Serebriiskii IG, Dunbrack RL, Robinson MK, Burtness B, Golemis EA. Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer. Drug Resistance Updates. 2011 Dec;14(6):260-79.   PMCID: PMC3195944
Reddy S, Shaller CC, Doss M, Shchaveleva I, Marks JD, Yu JQ, Robinson MK. Evaluation of the Anti-HER2 C6.5 Diabody as a PET Radiotracer to Monitor HER2 status and Predict Response to Trastuzumab Treatment. Clinical Cancer Research. 2011 Mar 15;17(6):1509-20.   PMCID: PMC3060271
Reddy S, Robinson MK. Immuno-positron emission tomography in cancer models. Semin Nucl Med. 2010 May;40(3):182-9.   PMCID: PMC2848398
Robinson MK, Alpaugh RK, Borghaei H. Naptumomab estafenatox: a new immunoconjugate. Expert Opinion on Biological Therapy. 2010 Feb;10(2):273-9.   PMCID: not NIH funded
Loo L, Robinson MK, Adams GP. Antibody engineering principles and applications. Cancer J. 2008 May;14(3):149-53.
Robinson MK, Hodge KM, Horak E, Sundberg AL, Russeva M, Shaller CC, von Mehren M, Shchaveleva I, Simmons HH, Marks JD, Adams GP. Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro. Br J Cancer. 2008 Nov 04;99(9):1415-25.   PMCID: PMC2576487
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Matthew Robinson Sparkline Graph

Graph Interactions

Co-Authors:

Similar Investigators:


Keywords (MeSH):


Last updated on Tuesday, October 10, 2017